Enshan Hong
Associate
Associate
Areas of Expertise
Counseling on Patent Validity, Infringement, and Freedom to Operate
Conducting due diligence investigations
Patent Prosecution
Patent Litigation
Professional Summary
Mr. Hong has been practicing intellectual property law since 1996. Mr. Hong currently focuses his practice on preparation of opinions on patent validity, infringement, and freedom to operate issues, conducting due diligence investigations, counseling clients related to the Hatch-Waxman Act, prosecution of patent applications, and representing clients in reexamination, reissue and patent term extension proceedings. Mr. Hong has also been involved in a number of patent litigations. His practice covers various technologies, including chemical compounds and processes, pharmaceutical formulations, herbal extracts, cosmetic products, nutritional supplements, medical treatment and diagnosis, medical devices, polymers, food processing, petroleum processing, catalysts, inkjet inks, and semiconductor materials. Mr. Hong has counseled a diverse group of clients ranging from individual inventors to multinational corporations.
Mr. Hong joined the firm in 2002 following five years of practice as a patent attorney in China. Prior to that he worked for five years as a chemical engineer. Mr. Hong began his legal career with a Fortune 500 Company, China Petroleum and Chemical Corporation (Sinopec), where his practice focused on intellectual property management, patent prosecution, patent validity, infringement, enforcement analysis, and patent strategy.
Education
J.D. Rutgers School of Law, Newark, 2008
M.S., Intellectual Property, Franklin Pierce Law Center, 2002
B.S., Chemical Engineering, China University of Petroleum (East China), 1991
Admissions
New York
New Jersey
U.S. District Court for the District of New Jersey
U.S. Patent and Trademark Office
China
State Intellectual Property Office of P.R. China
China Trademark Office
Memberships
New York Intellectual Property Law Association
Decisions
Inter parties rexamination on behalf of Gladerma R&D of Leo Pharmaceutical Products Ltd., US Patent No. 6,753,013 for TACLONEX (August 2008)
In re Metoprolol Succinate Patent Litigation, No. 2006-1254 (Fed. Cir. July 23, 2007).
Pharm. Res., Inc. v. Roxane Labs. Inc., No. 03-3357, 2006 U.S. Dist. LEXIS 81628, 2006 WL 3231427 (D.N.J. Nov. 8, 2006).
Dey LP v. IVAX Pharm. Inc., 233 F.R.D. 567 (C.D. Cal. 2005).
Articles
Chinese
Mr. Hong has been practicing intellectual property law since 1996. Mr. Hong currently focuses his practice on preparation of opinions on patent validity, infringement, and freedom to operate issues, conducting due diligence investigations, counseling clients related to the Hatch-Waxman Act, prosecution of patent applications, and representing clients in reexamination, reissue and patent term extension proceedings. Mr. Hong has also been involved in a number of patent litigations. His practice covers various technologies, including chemical compounds and processes, pharmaceutical formulations, herbal extracts, cosmetic products, nutritional supplements, medical treatment and diagnosis, medical devices, polymers, food processing, petroleum processing, catalysts, inkjet inks, and semiconductor materials. Mr. Hong has counseled a diverse group of clients ranging from individual inventors to multinational corporations.
Mr. Hong joined the firm in 2002 following five years of practice as a patent attorney in China. Prior to that he worked for five years as a chemical engineer. Mr. Hong began his legal career with a Fortune 500 Company, China Petroleum and Chemical Corporation (Sinopec), where his practice focused on intellectual property management, patent prosecution, patent validity, infringement, enforcement analysis, and patent strategy.
Education
J.D. Rutgers School of Law, Newark, 2008
M.S., Intellectual Property, Franklin Pierce Law Center, 2002
B.S., Chemical Engineering, China University of Petroleum (East China), 1991
Admissions
New York
New Jersey
U.S. District Court for the District of New Jersey
U.S. Patent and Trademark Office
China
State Intellectual Property Office of P.R. China
China Trademark Office
Memberships
New York Intellectual Property Law Association
Decisions
Inter parties rexamination on behalf of Gladerma R&D of Leo Pharmaceutical Products Ltd., US Patent No. 6,753,013 for TACLONEX (August 2008)
In re Metoprolol Succinate Patent Litigation, No. 2006-1254 (Fed. Cir. July 23, 2007).
Pharm. Res., Inc. v. Roxane Labs. Inc., No. 03-3357, 2006 U.S. Dist. LEXIS 81628, 2006 WL 3231427 (D.N.J. Nov. 8, 2006).
Dey LP v. IVAX Pharm. Inc., 233 F.R.D. 567 (C.D. Cal. 2005).
Articles
中国专利法中的现有技术抗辩制度之探讨
洪恩山《中国发明与专利》2010年第3期
Enshan Hong, Practicing The Prior Art under Chinese Patent Law, INVENTION & INNOVATION 2010 (3).
例析选择发明
洪恩山 李微 毕道毅 彭晓玲 《发明与创新》 2003年 第7期
Enshan Hong, Wei Li, Daoyi Bi, Xiaoling Peng, Analysis of Selection Invention with Examples, INVENTION & INNOVATION 2003 (7).
试析选择发明
洪恩山 李微 《发明与创新》 2003年 第2期
Enshan Hong, Wei Li, Analysis of Selection Invention, INVENTION & INNOVATION 2003 (2).
发明专利的新颖性和创造性
洪恩山 李微 《发明与革新》 2001年 第1期
Enshan Hong, Wei Li, Novelty and Inventiveness of Invention Patent, INVENTION & INNOVATION 2001 (1).
Chinese
